FI903571A0 - Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi - Google Patents

Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi

Info

Publication number
FI903571A0
FI903571A0 FI903571A FI903571A FI903571A0 FI 903571 A0 FI903571 A0 FI 903571A0 FI 903571 A FI903571 A FI 903571A FI 903571 A FI903571 A FI 903571A FI 903571 A0 FI903571 A0 FI 903571A0
Authority
FI
Finland
Prior art keywords
preparation
therapeutically active
active peptides
compounds
chem
Prior art date
Application number
FI903571A
Other languages
English (en)
Swedish (sv)
Other versions
FI94354C (fi
FI94354B (fi
Inventor
Pradip Kumar Bhatnagar
William Francis Huffman
James Edward Talmadge
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of FI903571A0 publication Critical patent/FI903571A0/fi
Application granted granted Critical
Publication of FI94354B publication Critical patent/FI94354B/fi
Publication of FI94354C publication Critical patent/FI94354C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI903571A 1989-07-14 1990-07-13 Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi FI94354C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38057889A 1989-07-14 1989-07-14
US38057889 1989-07-14

Publications (3)

Publication Number Publication Date
FI903571A0 true FI903571A0 (fi) 1990-07-13
FI94354B FI94354B (fi) 1995-05-15
FI94354C FI94354C (fi) 1995-08-25

Family

ID=23501712

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903571A FI94354C (fi) 1989-07-14 1990-07-13 Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi

Country Status (25)

Country Link
EP (1) EP0408371B1 (fi)
JP (1) JP2638666B2 (fi)
KR (1) KR910002899A (fi)
CN (1) CN1034663C (fi)
AT (1) ATE112289T1 (fi)
AU (1) AU638468B2 (fi)
CA (1) CA2020838C (fi)
DE (1) DE69012901T2 (fi)
DK (1) DK0408371T3 (fi)
ES (1) ES2064642T3 (fi)
FI (1) FI94354C (fi)
HK (1) HK1004554A1 (fi)
HU (1) HU206889B (fi)
IE (1) IE65533B1 (fi)
IL (1) IL95012A (fi)
MA (1) MA21902A1 (fi)
MX (1) MX21581A (fi)
MY (1) MY106352A (fi)
NO (1) NO177713C (fi)
NZ (1) NZ234501A (fi)
PH (1) PH30055A (fi)
PL (2) PL166004B1 (fi)
PT (1) PT94702B (fi)
ZA (1) ZA905505B (fi)
ZW (1) ZW11290A1 (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW222280B (fi) * 1991-11-26 1994-04-11 Smithkline Beecham Corp
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
GB9211677D0 (en) * 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
GB9211674D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
ATE172204T1 (de) * 1992-06-02 1998-10-15 Nycomed Imaging As Doppelsträngige peptidverbindungen mit hämoregulatorischer aktivität
GB9211668D0 (en) 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
ES2052447B1 (es) * 1992-12-14 1995-01-16 Smithkline Beecham Corp Peptidos hemorreguladores.
JPH08510258A (ja) * 1993-05-14 1996-10-29 マリンクロット・メディカル・インコーポレイテッド ペプチド内へ導入するための配位子前駆体
EP1378522A3 (en) * 1993-06-08 2004-02-04 SmithKline Beecham Corporation Methods of enhancing bioactivity of chemokines
GB9314200D0 (en) * 1993-07-09 1993-08-18 Hafslund Nycomed As Peptide compounds
US5652219A (en) * 1993-10-29 1997-07-29 Smithkline Beecham Corporation Hemoregulatory peptides
GB9324691D0 (en) * 1993-12-01 1994-01-19 Hafslund Nycomed As Peptide compounds
US5714469A (en) * 1994-09-01 1998-02-03 Smithkline Beecham Corporation Method of treating sepsis
TR199801569T2 (xx) * 1996-02-13 1998-10-21 Akzo Nobel N.V. Serin proteaz inhibit�rleri.
TW442452B (en) * 1996-03-01 2001-06-23 Akzo Nobel Nv Serine protease inhibitors having an alkynylamino side chain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000053B1 (en) * 1977-06-08 1981-05-27 Merck & Co. Inc. Somatostatin analogs, process for their preparation and pharmaceutical compositions containing them
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds

Also Published As

Publication number Publication date
PL166004B1 (pl) 1995-03-31
AU5901490A (en) 1991-01-17
EP0408371B1 (en) 1994-09-28
PH30055A (en) 1996-11-08
IL95012A (en) 1995-03-15
ZA905505B (en) 1991-04-24
EP0408371A1 (en) 1991-01-16
CN1054773A (zh) 1991-09-25
CA2020838A1 (en) 1991-01-15
PT94702A (pt) 1991-03-20
MA21902A1 (fr) 1991-04-01
CA2020838C (en) 2000-05-02
PT94702B (pt) 1997-04-30
ZW11290A1 (en) 1990-10-31
IE902547A1 (en) 1991-02-27
ES2064642T3 (es) 1995-02-01
ATE112289T1 (de) 1994-10-15
MY106352A (en) 1995-05-30
DE69012901D1 (de) 1994-11-03
NO177713C (no) 1995-11-08
DK0408371T3 (da) 1996-12-16
HU904201D0 (en) 1990-12-28
NO177713B (no) 1995-07-31
PL286043A1 (en) 1991-03-25
HU206889B (en) 1993-01-28
HUT55034A (en) 1991-04-29
NZ234501A (en) 1991-08-27
KR910002899A (ko) 1991-02-26
NO903148L (no) 1991-01-15
MX21581A (es) 1994-01-31
IL95012A0 (en) 1991-06-10
CN1034663C (zh) 1997-04-23
FI94354C (fi) 1995-08-25
AU638468B2 (en) 1993-07-01
JPH0356498A (ja) 1991-03-12
DE69012901T2 (de) 1995-02-16
PL165133B1 (pl) 1994-11-30
FI94354B (fi) 1995-05-15
NO903148D0 (no) 1990-07-13
JP2638666B2 (ja) 1997-08-06
HK1004554A1 (en) 1998-11-27
IE65533B1 (en) 1995-11-01

Similar Documents

Publication Publication Date Title
NO180719C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive A-nor-steroid-3-carboxylsyrederivater
FI892881A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten aminohappojohdannaisten va lmistamiseksi
FI860484A (fi) Menetelmä terapeuttisesti aktiivisten peptidijohdannaisten valmistamiseksi
NO180718C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive mercaptoacetylamidderivater
FI883064A (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
FI903571A0 (fi) Menetelmä farmaseuttisesti aktiivisten peptidien valmistamiseksi
NO882239L (no) Fremgangsmaate for fremstilling av terapeutisk aktive cykliske peptider.
NO882238D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cykliske peptider.
FI880467A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
NO173444C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 4-(4'- fluorfenyl-)-tienopyridin-derivater
FI104075B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-karboksitienyylikarbamoyylipyrrolidin-4-yylitiokarbapeneemi-3-karboksyylihappojohdannaisten valmistamiseksi
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
FI901883A0 (fi) Menetelmä terapeuttisesti vaikuttavien 2-substituoitujen N,N'-ditrimetoksibentsoyylipiperatsiinien valmistamiseksi
NO173991C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater
FI893121A (fi) Menetelmä farmakologisesti aktiivisten 6,21-dimetyyli-19-norprogesteronijohdannaisten valmistamiseksi
ATE10934T1 (de) Peptid, verfahren zu dessen herstellung und dessen verwendung.
NO954229L (no) Fremgangsmåte for fremstilling av terapeutisk aktive cykliske amidderivater
NO961910D0 (no) Fremgangsmåte for fremstilling av terapeutisk aktive polyamider
FI951697A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten hydroksialkylideenisyaanietikkahappoamidien valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: SMITHKLINE BEECHAM CORPORATION